CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ELDICO ED introduces a new electron diffractometer for analyzing nano-crystalline substances, overcoming limitations of traditional methods. This technology aims to expedite drug discovery by enabling the characterization of previously unmeasurable compounds.
Crystal structure determination is still a key issue in pharmaceutical industry.
Any compound requires its 3D atomic structure to become “fully characterized” for patenting and marketing approval.
However, only the structure of the 10% of all crystalline substances can be determine.
The reason:
Conventional X-ray diffraction methods are limited because they require crystal of a minimum size of 10 x 10 μm2 and high quality to be measured, which are often time consuming or even impossible to produ…
ELDICO SCIENTIFIC AG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
